Difference between revisions of "Improve Prescribing Practices"
user>Snkennedy3327 |
user>Josiebeets |
||
Line 43: | Line 43: | ||
== GuideMed == | == GuideMed == | ||
<div class="_">One option to essentially outsource some of the added requirements for opioid prescribing is to work with a third party that integrates with the prescribing process to follow the recommended best practices without adding to the burden of the prescribing physician. You can learn more about [https://guidemed.com/about-guidemed/how-it-works/ GuideMed at their Website] This added service allows insurance to be billed for a more complex [http://www.medicarepaymentandreimbursement.com/2010/10/time-guideline-for-99211-99212-99213.html Evaluation and Management code] (99213) instead of the typical code (99212), and this adds about $30 to the revenue for each visit. </div> <div class="_"> <span style="color: #272647; font-family: Verdana,sans-serif; font-size: 1.5em; letter-spacing: 1px">'''Tools & Resources'''</span><br/> [[TR_-_Improve_Prescribing_Practices|TR - Improve Prescribing Practices]]</div> <div class="_"> </div> | <div class="_">One option to essentially outsource some of the added requirements for opioid prescribing is to work with a third party that integrates with the prescribing process to follow the recommended best practices without adding to the burden of the prescribing physician. You can learn more about [https://guidemed.com/about-guidemed/how-it-works/ GuideMed at their Website] This added service allows insurance to be billed for a more complex [http://www.medicarepaymentandreimbursement.com/2010/10/time-guideline-for-99211-99212-99213.html Evaluation and Management code] (99213) instead of the typical code (99212), and this adds about $30 to the revenue for each visit. </div> <div class="_"> <span style="color: #272647; font-family: Verdana,sans-serif; font-size: 1.5em; letter-spacing: 1px">'''Tools & Resources'''</span><br/> [[TR_-_Improve_Prescribing_Practices|TR - Improve Prescribing Practices]]</div> <div class="_"> </div> | ||
<div class="mw-parser-output"> | |||
= Scorecard Building = | = Scorecard Building = | ||
Potential Objective Details(Under Construction )<br/> Potential Measures and Data Sources (Under Construction )<br/> Potential Actions and Partners(Under Construction ) | |||
</div> | |||
= Resources to Investigate = | = Resources to Investigate = |
Revision as of 16:29, 24 November 2019
Insurance Company Practices Contribute to Over-Prescription of Opioids
Prescribing should take Risk Factors into Consideration
Opioid Naive Patients
Multiple studies (five of which are referenced in this UpToDate article) have reported an increased risk of new persistent opioid use after prescription of opioids for acute pain in opioid naïve patients[3]
That article also states: "Importantly, post-surgical opioid prescription in opioid naïve patients is also associated with an increase in overdose and misuse."
Other Risk Factors
CDC Guidelines for Prescribing Opioids for Chronic Pain
- Non-opioid therapy is preferred for chronic pain outside of active cancer, palliative, and end-of-life care.
- When opioids are used, the lowest possible effective dosage should be prescribed to reduce risks of opioid use disorder and overdose.
- Providers should always exercise caution when prescribing opioids and monitor all patients closely.
The idea is to encourage doctors to be more cautious about prescribing opioids, making them less likely to distribute the drugs to patients who are prone to addiction or don't really need the medication. (The evidence on whether opioid painkillers can even treat chronic pain is weak at best.) And if doctors take up the recommendations, they could help stop one of the deadliest drug epidemics in US history.[5]
Source:https://www.cdc.gov/drugoverdose/prescribing/guideline.html
Ways to Improve Prescribing Practices
Improve Patient Education on the Risks of Using Opioids and the Alternatives
Use Tools Built into EHRs
EHRs are adding tools to support better prescribing practices for opioids.
MEDITECH is one example with ther new (2019) module, the Opioid Stewardship Toolkit
Adopt Policies That Compel Physicians To Utilize PDMPs
- Until states began requiring physicians to use prescription drug-monitoring programs, fewer than 35 percent of medical professionals used the tracking systems to identify patients who may be at risk for addiction and overdose. Now, in states that require doctors to consult PDMPs, physician usage rates exceed 90 percent.[6]
- Overall opioid prescribing has declined in those states as well, as have drug-related hospitalizations and overdose deaths. States also are seeing a rise in addiction treatment as more doctors refer patients to treatment after discovering they are taking painkillers from multiple sources and are likely addicted.
- In 2010, Colorado, Delaware, Louisiana, Nevada and Oklahoma were the first states to require doctors and other prescribers to search patients’ drug histories before prescribing opioid painkillers, sedatives or other potentially harmful and addictive drugs. By December 2016, at least 31 states were requiring prescriber use of PDMPs.
- This year (2017), eight more states — Alabama, Alaska, California, Florida, Michigan, South Carolina, Texas and Wisconsin — implemented policies requiring doctors to not only log in to the state’s prescription drug-tracking system before prescribing a controlled substance, but also to analyze each patient’s history of drug use, and if necessary, limit prescription renewals for opioids and other potentially addictive or dangerous medications.[7]
Improve Patient Education on the Risks of Opioids
An new technology-enhanced approach to patient understanding and education is available through DrProveIt.com
Approaches to Reduce Inappropriate Prescriptions
Ohio's Safety Checkpoints
[1]
GuideMed
Scorecard Building
Potential Objective Details(Under Construction )
Potential Measures and Data Sources (Under Construction )
Potential Actions and Partners(Under Construction )
Resources to Investigate
More RTI on Improve Prescribing Practices
PAGE MANAGER: [insert name here]
SUBJECT MATTER EXPERT: [fill out table below]
Reviewer | Date | Comments |